A Randomized Multicentre Phase Ii Study of Pazopanib Plus Best Supportive Care (Bsc) Vs Bsc Alone in Metastatic Gastrointestinal Stromal Tumors (Gist) Resistant to Imatinib and Sunitinib
- 1 September 2014
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 25, v1